Contact this trialFirst, we need to learn more about you.
Immunotherapy
YTB323 for Lupus
Recruiting1 awardPhase 1 & 2
Saint Louis, Missouri
This trial will look at how safe and effective YTB323 treatment is in patients with severe refractory systemic lupus erythematosus, and how the treatment affects the cells in their body.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service